Czech Republic Marketing Regulation

Healthcare regulations safeguard public health by ensuring accurate information and ethical marketing. They prevent misleading claims, promote responsible advertising, and require scientific evidence for product claims. This empowers patients with reliable information and protects them from misuse of medications. Regulations also ensure fair competition within the industry.
In the Czech Republic, the primary legal frameworks governing the advertising of medicines and medical devices are:
The SIDC provides additional instructions and explanations detailing the rules set out in the Advertising Act, offering more specific guidance on compliance.
There are no specific licenses, approvals, or fees required for advertising medicines or medical devices to either the general public or healthcare professionals in the Czech Republic.
General Requirements:
Only registered medicines and medical devices that meet the requirements of respective European legislation can be advertised.
Comparative advertising is permitted only if directed to healthcare professionals who are authorized to prescribe or dispense the products.
The same rules apply to advertising on the internet and social media as in other media. Additionally:
The State Institute for Drug Control (SIDC) is the primary body overseeing compliance with advertising regulations for medicines and medical devices, except for TV and radio broadcasts.
The SIDC can impose financial penalties up to CZK 5,000,000 (approximately EUR 190,000) for non-compliance.
In extreme cases, criminal liability may arise.
There are no specific future developments regarding the regulation of advertisements for medicines and medical devices in the Czech Republic at the moment.
However, an EU-level initiative concerning green claims may impact advertising activities for pharmaceutical and medical technology companies.
Join hundreds of companies who trust OMC Medical for their regulatory needs.